Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Anticipated ShortageTier 3 — Critical

DEXTROSE INJECTION USP

PFIZER CANADA ULC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of DEXTROSE INJECTION USP in Canada?

A shortage of DEXTROSE INJECTION USP 500MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated September 9, 2026), but it has not started yet.

Why is DEXTROSE INJECTION USP not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will DEXTROSE INJECTION USP be available again?

The manufacturer's estimated resolution date is February 15, 2027. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found
StatusAnticipated Shortage
Same-ingredient products on file2 products
Expected resolution~5 months remaining (estimate)
Affected strength500MG
Last updated2026-09-09

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

DEXTROSE INJ 50%

INTERNATIONAL MEDICATION SYSTEMS LTD.

500MG · DIN 00243566

Same strengthDifferent dosage formSame routeNo current shortage

GLUCOTOL LIQ 75GM/300ML LEMON LIME 75

ATLAS LABS CO LTD.

75G · DIN 00617814

Different strengthDifferent dosage formDifferent routeNo current shortage

What this means

Does this mean my pharmacy is already out of stock?

No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.

What should I do?

No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.

Estimated Resolution

2027-02-15

~5 months remaining (estimate)

This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.

DIN

02468514

Strength

500MG

Dosage Form

SOLUTION

Route

INTRAVENOUS

Active Ingredient

DEXTROSE

Tier

Tier 3 — Critical

Last Updated

2026-09-09

Reason for Shortage

Disruption of the manufacture of the drug.

Past Reports for This Drug

DEXTROSE INJECTION USP has 3 shortage/discontinuation reports on file — this is one of them.